Icecure Medical Ltd
NASDAQ:ICCM 4:00:00 PM EDT
| Market Cap (Intraday) | 53.50M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.21 |
| 50-Day MA | $1.25 |
| 200-Day MA | $1.09 |
Icecure Medical Ltd Stock, NASDAQ:ICCM
7 Ha'Eshel Street, Caesarea, Haifa 3079504
Phone: +972.4.623.0333
Number of Employees: 77
Description
IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.